• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hypertension and the renal vascular complications of diabetes: a structural basis to guide management.

作者信息

Viberti G C

机构信息

Unit for Metabolic Medicine, UMDS Guy's Hospital, London, United Kingdom.

出版信息

Schweiz Med Wochenschr. 1994 Nov 5;124(44):1938-40.

PMID:7973521
Abstract

The biochemical and structural alterations responsible for the renal and vascular complications of diabetes mellitus are likely to be the result of common processes. It is now well recognized that microalbuminuria is a powerful predictor of cardiovascular morbidity and mortality in diabetic patients. Increased cell growth and vascular tone and insulin resistance are among the contributors that lead to the renal and vascular complications of diabetes. Angiotensin-converting enzyme inhibitors, which may decrease the negative impact of these contributors, are effective therapeutic agents that reduce the risk of progression of renal disease and early mortality.

摘要

相似文献

1
Hypertension and the renal vascular complications of diabetes: a structural basis to guide management.
Schweiz Med Wochenschr. 1994 Nov 5;124(44):1938-40.
2
[Arterial hypertension and diabetes].[动脉高血压与糖尿病]
Rev Esp Cardiol. 1997;50 Suppl 4:33-48.
3
Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.微量白蛋白尿、胰岛素抵抗、糖尿病、高血压与肾功能:病理学及药物治疗的最新概念
Postgrad Med. 2005 Dec;118(6 Suppl Beta-Blockers):34-45. doi: 10.3810/pgm.12.2005.suppl43.230.
4
Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.血管紧张素转换酶抑制剂在患有微量白蛋白尿或正常白蛋白尿的糖尿病患者中的应用
Kidney Int Suppl. 1997 Dec;63:S32-5.
5
[What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].大型临床试验让我们了解到关于2型糖尿病合并高血压患者心血管和肾脏预防的哪些信息?
Nephrol Ther. 2006 May;2(2):51-74. doi: 10.1016/j.nephro.2006.01.004. Epub 2006 Mar 9.
6
[Control of arterial pressure in diabetic nephropathy].[糖尿病肾病中的动脉血压控制]
Nefrologia. 2001 May-Jun;21(3):240-5.
7
The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management.血管紧张素转换酶抑制剂在糖尿病中的新作用:从理论到治疗管理
J Diabetes Complications. 1996 May-Jun;10(3):129-32. doi: 10.1016/1056-8727(96)00034-7.
8
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂用于预防和治疗2型糖尿病相关肾病。
Pharmacotherapy. 2005 Nov;25(11):1602-20. doi: 10.1592/phco.2005.25.11.1602.
9
Microalbuminuria as a target to improve cardiovascular and renal outcomes.微量白蛋白尿作为改善心血管和肾脏预后的靶点。
Am J Kidney Dis. 2006 Jun;47(6):927-46. doi: 10.1053/j.ajkd.2006.02.182.
10
Microvascular hemodynamics in hypertension and diabetes.高血压和糖尿病中的微血管血流动力学
J Cardiovasc Pharmacol. 1991;18 Suppl 2:S51-3.